Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Collegium Pharma (COLL)

Collegium Pharma (COLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,025,939
  • Shares Outstanding, K 31,753
  • Annual Sales, $ 780,570 K
  • Annual Income, $ 62,870 K
  • EBIT $ 180 M
  • EBITDA $ 405 M
  • 60-Month Beta 0.77
  • Price/Sales 1.35
  • Price/Cash Flow 2.18
  • Price/Book 3.48

Options Overview Details

View History
  • Implied Volatility 63.45% (+5.78%)
  • Historical Volatility 38.69%
  • IV Percentile 77%
  • IV Rank 55.00%
  • IV High 88.16% on 03/11/26
  • IV Low 33.26% on 08/18/25
  • Expected Move (DTE 11) 2.46 (7.52%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 3
  • Volume Avg (30-Day) 7
  • Put/Call OI Ratio 0.40
  • Today's Open Interest 214
  • Open Int (30-Day) 276
  • Expected Range 30.22 to 35.14

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $1.50
  • Number of Estimates 2
  • High Estimate $1.57
  • Low Estimate $1.42
  • Prior Year $1.23
  • Growth Rate Est. (year over year) +21.95%

Price Performance

See More
Period Period Low Period High Performance
1-Month
31.72 +3.09%
on 04/06/26
37.76 -13.40%
on 03/10/26
-4.59 (-12.31%)
since 03/06/26
3-Month
31.72 +3.09%
on 04/06/26
49.31 -33.68%
on 02/05/26
-13.51 (-29.24%)
since 01/06/26
52-Week
23.23 +40.77%
on 04/10/25
50.79 -35.61%
on 12/29/25
+4.56 (+16.20%)
since 04/04/25

Most Recent Stories

More News
1 Value Stock on Our Buy List and 2 Facing Headwinds

1 Value Stock on Our Buy List and 2 Facing Headwinds

COLL : 32.58 (+0.84%)
HAE : 57.81 (+1.72%)
WT : 14.79 (+2.35%)
GE HealthCare and Collegium Pharmaceutical Stocks Trade Down, What You Need To Know

GE HealthCare and Collegium Pharmaceutical Stocks Trade Down, What You Need To Know

COLL : 32.58 (+0.84%)
GEHC : 70.32 (-0.04%)
2 Profitable Stocks to Consider Right Now and 1 We Question

2 Profitable Stocks to Consider Right Now and 1 We Question

COLL : 32.58 (+0.84%)
MOH : 143.68 (+3.09%)
MCO : 443.97 (+0.72%)
Branded Pharmaceuticals Stocks Q4 Recap: Benchmarking Collegium Pharmaceutical (NASDAQ:COLL)

Branded Pharmaceuticals Stocks Q4 Recap: Benchmarking Collegium Pharmaceutical (NASDAQ:COLL)

COLL : 32.58 (+0.84%)
Collegium to Acquire AZSTARYS® from Corium Therapeutics, Strengthening Position in ADHD and Accelerating Growth Trajectory

– Adds Highly Complementary and Differentiated Medicine with Significant Growth Potential to Collegium’s Existing ADHD Portfolio – – Enables Greater Impact Across ADHD Patient Communities...

COLL : 32.58 (+0.84%)
BrightSpring Health Services, Collegium Pharmaceutical, and Phibro Animal Health Shares Are Soaring, What You Need To Know

BrightSpring Health Services, Collegium Pharmaceutical, and Phibro Animal Health Shares Are Soaring, What You Need To Know

COLL : 32.58 (+0.84%)
BTSG : 43.72 (+1.44%)
PAHC : 54.64 (-1.59%)
3 Healthcare Stocks Walking a Fine Line

3 Healthcare Stocks Walking a Fine Line

COLL : 32.58 (+0.84%)
JAZZ : 187.09 (+0.07%)
BDX : 154.93 (+0.27%)
Collegium to Present New Real-World Data at PainConnect 2026

STOUGHTON, Mass., March 05, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced it will present two posters featuring real-world data from its portfolio of differentiated...

COLL : 32.58 (+0.84%)
Paris Hilton Shares Her Experience with JORNAY PM and Launches New 'Embrace Your Sparkle' Campaign with Collegium to Empower the ADHD Community

– Paris Hilton shares her personal ADHD journey and encourages others to see ADHD in a new light – – Together, Paris and Collegium are reframing common stereotypes and highlighting experiences...

COLL : 32.58 (+0.84%)
Collegium to Participate in Upcoming Investor Conferences

STOUGHTON, Mass., March 02, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc.  (Nasdaq: COLL) today announced that its management will participate in the following investor conferences: Leerink...

COLL : 32.58 (+0.84%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strengthening short term outlook on maintaining the current direction.

Relative Strength just crossed above 30%. The market has bounced from oversold territory. Beware of a potential mean reversion.

See More Share

Business Summary

Collegium Pharmaceutical Inc. is a specialty pharmaceutical company. It develops and commercializes prescription and over-the-counter pharmaceuticals for the treatment of central nervous system, respiratory and skin related disorders. The Company's product candidate consists of COL-195, COL-196, COL-171,...

See More

Key Turning Points

3rd Resistance Point 34.27
2nd Resistance Point 33.79
1st Resistance Point 33.05
Last Price 32.58
1st Support Level 31.83
2nd Support Level 31.35
3rd Support Level 30.61

See More

52-Week High 50.79
Fibonacci 61.8% 40.26
Fibonacci 50% 37.01
Fibonacci 38.2% 33.76
Last Price 32.58
52-Week Low 23.23

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.